PKP2

Clinical trials for PKP2 explained in plain language.

Never miss a new study

Get alerted when new PKP2 trials appear

Sign up with your email to follow new studies for PKP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug IC14 targets heart inflammation in rare condition

Disease control Completed

This early-phase study tested a drug called IC14 in one person with arrhythmogenic cardiomyopathy, a rare heart condition that can cause dangerous rhythms. The goal was to see if the drug is safe and reduces inflammation, which may help control the disease. Participants received …

Matched conditions: PKP2

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated May 22, 2026 14:03 UTC

PKP2

Get alerted when new PKP2 trials appear

New drug IC14 targets heart inflammation in rare condition